Detalhe da pesquisa
1.
Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy.
Front Immunol
; 14: 1274781, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38259453